Category Archives: Public Policy

Latest From Public Policy

Brazilian Innovation: A Patent Success

plant

The story of Acheflan highlights the role of patents in homegrown innovation in developing countries.  Professor Michael Ryan of George Washington University Law School reviewed several case studies (including Acheflan) in Brazil that highlight the differences in biomedical innovation both pre- and post-intellectual property reforms. In the early 1980’s, Ache Laboratorios Farmaceuticos (a Brazilian generics manufacturer) became aware of a plant that grew near coastal cities that local fishermen would mash into an oil rub Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,

Governors Talk Biotech in State of the State Addresses

Governor

State legislatures throughout the country are back in session – or soon will be. That means it is time for governors to deliver their annual state of the state addresses. In fact, several have already happened. Just in the last week, Missouri Governor Jay Nixon and West Virginia Governor Earl Ray Tomlin made reference to the biotech industry as an important part of their economic development strategy. As the economy continues to slowly chug upward, Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , ,

Virginia Governor McDonnell Aims to Lure Biotech Jobs

Virginia Gov. Bob McDonnell

Virginia Gov. Bob McDonnell unveiled an economic development package Wednesday that includes $37 million to lure businesses and jobs to the commonwealth. Nearly one quarter of which is earmarked for life sciences and biotechnology industry development — sectors that are staples of the economy of neighboring Maryland. The announcement was made during a press conference, in which Virginia Lt. Gov. Bill Bolling said “There, frankly, are a lot of states around the country over the Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , ,

2012: A Critical Year for Biotechnology

U.S. Capitol Building - Congress

In 2012, we must continue to look for ways to reduce risk; enhance reward; reduce uncertainty; and reinforce the position of the industry as a major contributor resolving society’s most pressing needs. Policies to encourage investment in innovation and to speed discovery to scientific breakthroughs simply must be the priority in 2012. The industry relies on a policy and regulatory environment that encourages innovation for much needed treatments and cures for some of the most Read More >

Public Policy  |  1 Comment  |  Email This Post
Tags: , , , , , ,

Biomedical Innovation: How the U.S. Can Stay Number One

lab_tech02-thumb

By Ross DeVol, chief research officer of the Milken Institute “The first step in winning the future is encouraging American innovation,” declared President Obama in his last State of the Union speech. A logical place to start is making sure that where we hold a lead, we keep it. Today, the U.S. has such a lead in biomedical innovation — the process of transforming scientific discoveries into vaccines, diagnostics, devices and therapies that improve and Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,